Metabolic protein phosphoglycerate kinase 1 confers lung cancer migration by directly binding HIV Tat specific factor 1
Open Access
- 5 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cell Death Discovery
- Vol. 7 (1), 1-15
- https://doi.org/10.1038/s41420-021-00520-1
Abstract
Phosphoglycerate kinase (PGK) is involved in glycolytic and various metabolic events. Dysfunction of PGK may induce metabolic reprogramming and the Warburg effect. In this study, we demonstrated that PGK1, but not PGK2, may play a key role in tumorigenesis and is associated with metastasis. We observed an inverse correlation between PGK1 and the survival rate in several clinical cohorts through bioinformatics statistical and immunohistochemical staining analyses. Surprisingly, we found that PGK1 was significantly increased in adenocarcinoma compared with other subtypes. Thus, we established a PGK1-based proteomics dataset by a pull-down assay. We further investigated HIV-1 Tat Specific Factor 1 (HTATSF1), a potential binding partner, through protein–protein interactions. Then, we confirmed that PGK1 indeed bound to HTATSF1 by two-way immunoprecipitation experiments. In addition, we generated several mutant clones of PGK1 through site-directed mutagenesis, including mutagenesis of the N-terminal region, the enzyme catalytic domain, and the C-terminal region. We observed that even though the phosphoglycerate kinase activity had been inhibited, the migration ability induced by PGK1 was maintained. Moreover, our immunofluorescence staining also indicated the translocation of PGK1 from the cytoplasm to the nucleus and its colocalization with HTATSF1. From the results presented in this study, we propose a novel model in which the PGK1 binds to HTATSF1 and exerts functional control of cancer metastasis. In addition, we also showed a nonenzymatic function of PGK1.Keywords
This publication has 46 references indexed in Scilit:
- PGK1 is a Potential Survival Biomarker and Invasion Promoter by Regulating the HIF-1α–Mediated Epithelial-Mesenchymal Transition Process in Breast CancerCellular Physiology and Biochemistry, 2018
- Nuclear PGK1 Alleviates ADP-Dependent Inhibition of CDC7 to Promote DNA ReplicationMolecular Cell, 2018
- A metabolite-derived protein modification integrates glycolysis with KEAP1–NRF2 signallingNature, 2018
- Nuclear translocation of PKM2/AMPK complex sustains cancer stem cell populations under glucose restriction stressCancer Letters, 2018
- Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3/miR-143 axisCancer Chemotherapy and Pharmacology, 2017
- Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesisJournal of Hepatology, 2016
- Down-Regulated Phosphoglycerate Kinase 1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder CancerMedicine, 2015
- Tissue-based map of the human proteomeScience, 2015
- Molecular Insights on Pathogenic Effects of Mutations Causing Phosphoglycerate Kinase DeficiencyPLOS ONE, 2012
- Selection of Invasive and Metastatic Subpopulations from a Human Lung Adenocarcinoma Cell LineAmerican Journal of Respiratory Cell and Molecular Biology, 1997